Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2019 Jun 3;9(6):215.
doi: 10.3390/biom9060215.

The Effectiveness of Herbal Mixture Supplements with and without Clomiphene Citrate in Comparison to Clomiphene Citrate on Serum Antioxidants and Glycemic Biomarkers in Women with Polycystic Ovary Syndrome Willing to be Pregnant: A Randomized Clinical Trial

Affiliations
Randomized Controlled Trial

The Effectiveness of Herbal Mixture Supplements with and without Clomiphene Citrate in Comparison to Clomiphene Citrate on Serum Antioxidants and Glycemic Biomarkers in Women with Polycystic Ovary Syndrome Willing to be Pregnant: A Randomized Clinical Trial

Nava Ainehchi et al. Biomolecules. .

Abstract

This paper aimed to evaluate the effect of herbal mixture (Mentha spicata, Zingiberofficinale, Cinnamomumzeylanicum, and Citrussinensis) only and along with clomiphene citrate (CC) compared to CC on serum antioxidants, glycemic status, menstrual regulation, and rate of pregnancy. This single-blind randomized clinical trial was carried out on 60 infertile participants with polycystic ovary syndrome (PCOS) willing to be pregnant. They were randomly allocated into group 1 (n = 20) who received routine dose of CC pills (50-150 mg) for three menstrual cycles from the fifth day of menstruation for five days; group 2 (n = 20) who consumed herbal mixture daily (700 mg); and group 3 (n = 20) who used up herbal mixture along with CC for 3 months. Catalase (CAT), glutathione peroxidase (GPx), superoxide dismutase (SOD), malondialdehyde (MDA), fasting blood sugar (FBS), insulin, and homeostatic model assessment for insulin resistance (HOMA-IR) were measured in their blood samples. No statistically significant differences were observed between the three groups in terms of socio-demographic characteristics. After intervention, however, the levels of CAT in group 2 (adjusted mean difference (aMD): = 9.0; confidence interval (CI) 95% = 1.1-16.9) and group 3 (aMD = 12.2; CI 95% = 4.5-19.9), GPx in group 2 (aMD = 986.1; CI 95% = 141.1-1831.1) and group 3 (aMD = 1781.2; CI 95% = 960.7-2601.8), and SOD in group 2 (aMD = 55.1; CI 95% = 26.0-84.2) increased. While FBS in group 3 (aMD = -8.7; CI 95% = -14.7 to -2.7), insulin in group 2 (aMD = -5.6; CI 95% = -10.8 to -0.4), and HOMA-IR in group 2 (aMD = -1.3; CI 95% = -2.4 to -0.2) significantly decreased compared to the group 1. To summarize, herbal mixture supplements along with CC have beneficial effects on serum antioxidant levels, as well as glycemic biomarkers of infertile PCOS, menstrual regulation, and pregnancy rate.

Keywords: PCOS; clomiphene citrate; enzymatic antioxidants; glycemic index; herbal mixture; insulin resistance.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interests.

Figures

Figure 1
Figure 1
Gas chomatography–mass chromatogram (GC–MS) of the essential oil of herbal mixture. TIC*1.00: total ion current (1.0 std).
Figure 2
Figure 2
Polycystic ovary syndrome (PCOS) patients’ flow diagram. Group 1: Clomiphene citrate (CC), group 2: Herbal mixture, and group 3: CC along with herbal mixture. IUI: intrauterine insemination, IVF: in vitro fertilization.

References

    1. Szczuko M., Skowronek M., Zapalowska-Chwyc M., Starczewski A. Quantitative assessment of nutrition in patients with polycystic ovary syndrome (PCOS) Roczniki Panstwowego Zakladu Higieny. 2016;67:419–426. - PubMed
    1. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS) Hum. Reprod. 2004;19:41–47. doi: 10.1093/humrep/deh098. - DOI - PubMed
    1. Murri M., Luque-Ramirez M., Insenser M., Ojeda-Ojeda M., Escobar-Morreale H.F. Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): A systematic review and meta-analysis. Hum. Reprod. Updat. 2013;19:268–288. doi: 10.1093/humupd/dms059. - DOI - PubMed
    1. Ehrmann D.A. Polycystic ovary syndrome. N. Engl. J. Med. 2005;352:1223–1236. doi: 10.1056/NEJMra041536. - DOI - PubMed
    1. Agarwal A., Allamaneni S.S. Role of free radicals in female reproductive diseases and assisted reproduction. Reprod. Biomed. Online. 2004;9:338–347. doi: 10.1016/S1472-6483(10)62151-7. - DOI - PubMed

Publication types